Cargando…
Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a Patient
Warfarin is a widely prescribed anticoagulant but the doses required to attain the optimum therapeutic effect exhibit dramatic inter-individual variability. Pharmacogenomics-guided warfarin dosing has been recommended to improve safety and effectiveness. We analyzed the cytochrome P450 2C9 (CYP2C9)...
Autores principales: | Zhou, Xiao-Yang, Lu, Xiang-Ran, Li, Ying-Hui, Ma, Ya-Qing, Zhao, Shi-Wen, Wang, Fang, Xu, Ren-Ai, Hu, Guo-Xin, Cai, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905303/ https://www.ncbi.nlm.nih.gov/pubmed/33643050 http://dx.doi.org/10.3389/fphar.2021.619339 |
Ejemplares similares
-
Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro
por: Zhou, Xiao-Yang, et al.
Publicado: (2019) -
Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022) -
Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells
por: Du, Huihui, et al.
Publicado: (2016) -
Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro
por: Fang, Ping, et al.
Publicado: (2017) -
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
por: Del Tredici, Andria L., et al.
Publicado: (2018)